Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.74ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.6.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.238ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.238ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.238ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.238NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.68ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.68NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BR.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BR.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.51ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.51NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used